Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.
Acceptance
COVID-19
Diaspora
Hesitancy
Locals
Resistance
Sub-Sahara Africa
Vaccination
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
28 01 2023
28 01 2023
Historique:
received:
05
04
2022
accepted:
23
01
2023
entrez:
28
1
2023
pubmed:
29
1
2023
medline:
1
2
2023
Statut:
epublish
Résumé
The COVID-19 vaccines are being rolled out across all the sub-Saharan Africa (SSA) countries, with countries setting targets for achieving full vaccination rates. The aim of this study was to compare the uptake of, resistance and hesitancy to the COVID-19 vaccine between SSA locally residents and in the diasporan dwellers. This was a cross-sectional study conducted using a web and paper-based questionnaire to obtain relevant information on COVID-19 vaccine acceptance. The survey items included questions on demography, uptake and planned acceptance or non-acceptance of the COVID-19 vaccines among SSAs. Multinomial logistic regression was used to determine probabilities of outcomes for factors associated with COVID-19 vaccination resistance and hesitancy among SSA respondents residing within and outside Africa. Uptake of COVID-19 vaccines varied among the local (14.2%) and diasporan (25.3%) dwellers. There were more locals (68.1%) who were resistant to COVID-19 vaccine. Participants' sex [adjusted relative risk (ARR) = 0.73, 95% CI: 0.58 - 0.93], education [primary/less: ARR = 0.22, CI:0.12 - 0.40, and bachelor's degree: ARR = 0.58, CI: 0.43 - 0.77]), occupation [ARR = 0.32, CI: 0.25-0.40] and working status [ARR = 1.40, CI: 1.06-1.84] were associated with COVID-19 vaccine resistance among locals. Similar proportion of local and diasporan dwellers (~ 18% each) were hesitant to COVID-19 vaccine, and this was higher among health care workers [ARR = 0.25, CI: 0.10 - 0.62 and ARR = 0.24, CI:0.18-0.32, diaspora and locals respectively]. After adjusting for the potential confounders, local residents aged 29-38 years [ARR = 1.89, CI: 1.26-2.84] and lived in East Africa [ARR = 4.64, CI: 1.84-11.70] were more likely to report vaccine hesitancy. Knowledge of COVID vaccines was associated with hesitancy among local and diasporan dwellers, but perception was associated with vaccine resistance [ARR = 0.86,CI: 0.82 - 0.90] and hesitancy [ARR = 0.85, CI: 0.80 - 0.90], only among the local residents. Differences exist in the factors that influence COVID-19 vaccine acceptance between local SSA residents and thediasporan dwellers. Knowledge about COVID-19 vaccines affects the uptake, resistance, and hesitancy to the COVID-19 vaccine. Information campaigns focusing on the efficacy and safety of vaccines could lead to improved acceptance of COVID-19 vaccines.
Sections du résumé
BACKGROUND
The COVID-19 vaccines are being rolled out across all the sub-Saharan Africa (SSA) countries, with countries setting targets for achieving full vaccination rates. The aim of this study was to compare the uptake of, resistance and hesitancy to the COVID-19 vaccine between SSA locally residents and in the diasporan dwellers.
METHODS
This was a cross-sectional study conducted using a web and paper-based questionnaire to obtain relevant information on COVID-19 vaccine acceptance. The survey items included questions on demography, uptake and planned acceptance or non-acceptance of the COVID-19 vaccines among SSAs. Multinomial logistic regression was used to determine probabilities of outcomes for factors associated with COVID-19 vaccination resistance and hesitancy among SSA respondents residing within and outside Africa.
RESULTS
Uptake of COVID-19 vaccines varied among the local (14.2%) and diasporan (25.3%) dwellers. There were more locals (68.1%) who were resistant to COVID-19 vaccine. Participants' sex [adjusted relative risk (ARR) = 0.73, 95% CI: 0.58 - 0.93], education [primary/less: ARR = 0.22, CI:0.12 - 0.40, and bachelor's degree: ARR = 0.58, CI: 0.43 - 0.77]), occupation [ARR = 0.32, CI: 0.25-0.40] and working status [ARR = 1.40, CI: 1.06-1.84] were associated with COVID-19 vaccine resistance among locals. Similar proportion of local and diasporan dwellers (~ 18% each) were hesitant to COVID-19 vaccine, and this was higher among health care workers [ARR = 0.25, CI: 0.10 - 0.62 and ARR = 0.24, CI:0.18-0.32, diaspora and locals respectively]. After adjusting for the potential confounders, local residents aged 29-38 years [ARR = 1.89, CI: 1.26-2.84] and lived in East Africa [ARR = 4.64, CI: 1.84-11.70] were more likely to report vaccine hesitancy. Knowledge of COVID vaccines was associated with hesitancy among local and diasporan dwellers, but perception was associated with vaccine resistance [ARR = 0.86,CI: 0.82 - 0.90] and hesitancy [ARR = 0.85, CI: 0.80 - 0.90], only among the local residents.
CONCLUSIONS
Differences exist in the factors that influence COVID-19 vaccine acceptance between local SSA residents and thediasporan dwellers. Knowledge about COVID-19 vaccines affects the uptake, resistance, and hesitancy to the COVID-19 vaccine. Information campaigns focusing on the efficacy and safety of vaccines could lead to improved acceptance of COVID-19 vaccines.
Identifiants
pubmed: 36709269
doi: 10.1186/s12889-023-15116-w
pii: 10.1186/s12889-023-15116-w
pmc: PMC9884132
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
191Informations de copyright
© 2023. The Author(s).
Références
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49):
pubmed: 34795017
Int J Infect Dis. 2021 Mar;104:742-745
pubmed: 33556610
JAMA Netw Open. 2021 Aug 02;4(8):e2121931
pubmed: 34459907
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
Vaccine. 2020 Jan 29;38(5):1160-1169
pubmed: 31791811
Risk Manag Healthc Policy. 2021 Jun 21;14:2609-2623
pubmed: 34188572
Niger Postgrad Med J. 2020 Oct-Dec;27(4):261-267
pubmed: 33154276
PLoS One. 2021 Sep 3;16(9):e0257109
pubmed: 34478470
Pediatr Nurs. 2005 Sep-Oct;31(5):380-6
pubmed: 16295153
Pan Afr Med J. 2021 Sep 03;40:10
pubmed: 34650660
BMC Public Health. 2021 Aug 18;21(1):1562
pubmed: 34404377
J Public Health (Oxf). 2018 Mar 1;40(1):121-128
pubmed: 28369548
Vaccines (Basel). 2021 Mar 12;9(3):
pubmed: 33809002
Brain Behav Immun. 2021 May;94:41-50
pubmed: 33713824
J Gen Intern Med. 2021 Jul;36(7):2130-2133
pubmed: 33754319
Am J Infect Control. 2022 Jan;50(1):20-25
pubmed: 34653527
Cureus. 2021 Sep 15;13(9):e17990
pubmed: 34667668
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915975
Health Secur. 2021 Jan-Feb;19(1):44-56
pubmed: 33606572
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
PLoS One. 2021 Apr 23;16(4):e0250555
pubmed: 33891660
J Relig Health. 2021 Feb;60(1):65-80
pubmed: 33125543
Vaccine. 2022 Jan 3;40(1):151-161
pubmed: 34863621
J Med Virol. 2022 Apr;94(4):1738-1744
pubmed: 34905235
JAMA. 2022 Feb 8;327(6):583-584
pubmed: 34967859
Vaccines (Basel). 2022 Feb 10;10(2):
pubmed: 35214724
Vaccine. 2022 Mar 8;40(11):1643-1654
pubmed: 33933316
J Med Internet Res. 2020 Apr 2;22(4):e18790
pubmed: 32240094
Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312
pubmed: 33118868
BMJ Open. 2018 May 17;8(5):e021006
pubmed: 29773702
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Lancet. 2021 Apr 3;397(10281):1265-1275
pubmed: 33773118
BMJ. 2021 May 20;373:n1138
pubmed: 34016653
PLoS One. 2021 Nov 29;16(11):e0260672
pubmed: 34843594
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696172
Front Microbiol. 2020 Mar 17;11:372
pubmed: 32256465
Int J Health Plann Manage. 2021 Jul;36(4):1178-1188
pubmed: 33819370
Procedia Vaccinol. 2011;5:127-136
pubmed: 32288915
Int J MCH AIDS. 2021;10(1):134-138
pubmed: 33868778
Clin Infect Dis. 2022 Sep 14;75(5):893-896
pubmed: 35134167
Lancet Microbe. 2021 Jul;2(7):e279-e280
pubmed: 33899038
JAMA Netw Open. 2021 Sep 1;4(9):e2126882
pubmed: 34559232
PLoS One. 2021 Dec 1;16(12):e0260575
pubmed: 34851998
Biomed J. 2020 Aug;43(4):328-333
pubmed: 32387617
PLoS One. 2021 Dec 21;16(12):e0260731
pubmed: 34932583
Viruses. 2022 Jan 30;14(2):
pubmed: 35215887